These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22823128)

  • 1. Systems biology visualization tools for drug target discovery.
    Huan T; Wu X; Chen JY
    Expert Opin Drug Discov; 2010 May; 5(5):425-39. PubMed ID: 22823128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational systems approach for drug target discovery.
    Chandra N
    Expert Opin Drug Discov; 2009 Dec; 4(12):1221-36. PubMed ID: 23480463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What does systems biology mean for biomarker discovery?
    Azuaje F
    Expert Opin Med Diagn; 2010 Jan; 4(1):1-10. PubMed ID: 23496106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based apoptosis assays in oncology drug discovery.
    Drewe J; Cai SX
    Expert Opin Drug Discov; 2010 Jun; 5(6):583-96. PubMed ID: 22823169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
    Franco R; Canela EI; Casado V; Ferre S
    Expert Opin Drug Discov; 2010 Apr; 5(4):391-403. PubMed ID: 22823089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors.
    Eglen RM; Reisine T
    Expert Opin Drug Discov; 2010 Mar; 5(3):277-90. PubMed ID: 22823023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology in drug discovery.
    Butcher EC; Berg EL; Kunkel EJ
    Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of web ontology languages and other semantic web tools in drug discovery.
    Chen H; Xie G
    Expert Opin Drug Discov; 2010 May; 5(5):413-23. PubMed ID: 22823127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigating permeability-mediated risks in drug discovery.
    Wang J; Skolnik S
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):171-87. PubMed ID: 20064074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.
    Xu X; Yang W; Li Y; Wang Y
    Expert Opin Drug Discov; 2010 Jan; 5(1):21-31. PubMed ID: 22823969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analyses for the discovery of tuberculosis drug targets.
    Chung BK; Dick T; Lee DY
    J Antimicrob Chemother; 2013 Dec; 68(12):2701-9. PubMed ID: 23838951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of targets and inhibitors of protein palmitoylation.
    Planey SL; Zacharias DA
    Expert Opin Drug Discov; 2010 Feb; 5(2):155-64. PubMed ID: 22822915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ariadne's ChemEffect and Pathway Studio knowledge base.
    Yuryev A; Kotelnikova E; Daraselia N
    Expert Opin Drug Discov; 2009 Dec; 4(12):1307-18. PubMed ID: 23480468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems biology approaches and tools for analysis of interactomes and multi-target drugs.
    Schrattenholz A; Groebe K; Soskic V
    Methods Mol Biol; 2010; 662():29-58. PubMed ID: 20824465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of phage display technology for the determination of the targets for small-molecule therapeutics.
    Takakusagi Y; Takakusagi K; Sugawara F; Sakaguchi K
    Expert Opin Drug Discov; 2010 Apr; 5(4):361-89. PubMed ID: 22823088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling to identify druggable targets in prion diseases.
    Benetti F; Gasperini L; Zampieri M; Legname G
    Expert Opin Drug Discov; 2010 Feb; 5(2):177-202. PubMed ID: 22822917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical metabolomics in drug discovery.
    Wilcoxen KM; Uehara T; Myint KT; Sato Y; Oda Y
    Expert Opin Drug Discov; 2010 Mar; 5(3):249-63. PubMed ID: 22823021
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.